FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2012271610> ?p ?o ?g. }

• W2012271610 endingPage "31" @default.
• W2012271610 startingPage "25" @default.
• W2012271610 abstract "HIV-infected patients receiving antiretroviral (ARV) therapy (ART) in India are not all adequately virally suppressed. We analyzed ARV drug resistance in adults receiving ART in three private clinics in Mumbai, India. HIV viral load was measured in 200 patients with the Roche AMPLICOR HIV-1 Monitor Test, v1.5. HIV genotyping was performed with the ViroSeq HIV-1 Genotyping System for 61 participants who had HIV-1 RNA >1000 copies/ml. Genotyping results were obtained for 51 samples. The participants with resistance results were on ART for a median of 24 months and were on their current regimen for a median of 12 months (median CD4 cell count: 217 cells/mm3; median HIV viral load: 28,200 copies/ml). ARV regimens included nonnucleoside reverse transcriptase inhibitor (NNRTI)-based regimens (n = 27), dual nucleoside reverse transcriptase inhibitors (NRTIs, n = 19), protease inhibitor (PI)-based regimens (n = 3), and other regimens (n = 2). Twenty-six participants (51.0%) were on their first ARV regimen and 24 (47%) reported >95% adherence. Forty-nine participants (96.1%) had resistance to at least one ARV drug; 47 (92.2%) had NRTI resistance, 32 (62.7%) had NNRTI resistance, and four (7.8%) had PI resistance. Thirty (58.8%) had two-class resistance and three (5.9%) had three-class resistance. Four (8%) had three or more resistance mutations associated with etravirine resistance and two (4%) had two mutations associated with reduced darunavir susceptibility. Almost all patients with HIV-1 RNA >1000 copies/ml had NRTI resistance and nearly two-thirds had NNRTI resistance; PI resistance was uncommon. Nearly 60% and 6% had two- and three-class resistance, respectively. This emphasizes the need for greater viral load and resistance monitoring, use of optimal ART combinations, and increased availability of second- and third-line agents for patients with ARV resistance." @default.
• W2012271610 created "2016-06-24" @default.
• W2012271610 creator A5000451929 @default.
• W2012271610 creator A5005879554 @default.
• W2012271610 creator A5007360478 @default.
• W2012271610 creator A5007774900 @default.
• W2012271610 creator A5009234755 @default.
• W2012271610 creator A5029893660 @default.
• W2012271610 creator A5033560168 @default.
• W2012271610 creator A5041745058 @default.
• W2012271610 creator A5042096090 @default.
• W2012271610 creator A5045230785 @default.
• W2012271610 creator A5046296775 @default.
• W2012271610 creator A5047405500 @default.
• W2012271610 creator A5049719522 @default.
• W2012271610 creator A5081294489 @default.
• W2012271610 date "2010-01-01" @default.
• W2012271610 modified "2023-09-25" @default.
• W2012271610 title "One-, Two-, and Three-Class Resistance among HIV-Infected Patients on Antiretroviral Therapy in Private Care Clinics: Mumbai, India" @default.
• W2012271610 cites W141166944 @default.
• W2012271610 cites W1513501726 @default.
• W2012271610 cites W1557613478 @default.
• W2012271610 cites W169362451 @default.
• W2012271610 cites W1982448824 @default.
• W2012271610 cites W1986351652 @default.
• W2012271610 cites W1988473616 @default.
• W2012271610 cites W1999749052 @default.
• W2012271610 cites W2007824615 @default.
• W2012271610 cites W2019065964 @default.
• W2012271610 cites W2021809965 @default.
• W2012271610 cites W2042718973 @default.
• W2012271610 cites W2046362234 @default.
• W2012271610 cites W2060969737 @default.
• W2012271610 cites W2070137192 @default.
• W2012271610 cites W2074093427 @default.
• W2012271610 cites W2077411387 @default.
• W2012271610 cites W2084373400 @default.
• W2012271610 cites W2086724358 @default.
• W2012271610 cites W2088423598 @default.
• W2012271610 cites W2088742233 @default.
• W2012271610 cites W2099621457 @default.
• W2012271610 cites W2102741140 @default.
• W2012271610 cites W2108466054 @default.
• W2012271610 cites W2129621295 @default.
• W2012271610 cites W2165600357 @default.
• W2012271610 cites W2170507689 @default.
• W2012271610 cites W2318289184 @default.
• W2012271610 cites W2480142188 @default.
• W2012271610 cites W2167320016 @default.
• W2012271610 cites W2414698896 @default.
• W2012271610 doi "https://doi.org/10.1089/aid.2009.0102" @default.
• W2012271610 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2858895" @default.
• W2012271610 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20063995" @default.
• W2012271610 hasPublicationYear "2010" @default.
• W2012271610 type Work @default.
• W2012271610 sameAs 2012271610 @default.
• W2012271610 citedByCount "19" @default.
• W2012271610 countsByYear W20122716102012 @default.
• W2012271610 countsByYear W20122716102013 @default.
• W2012271610 countsByYear W20122716102014 @default.
• W2012271610 countsByYear W20122716102015 @default.
• W2012271610 countsByYear W20122716102016 @default.
• W2012271610 countsByYear W20122716102017 @default.
• W2012271610 countsByYear W20122716102018 @default.
• W2012271610 countsByYear W20122716102019 @default.
• W2012271610 countsByYear W20122716102022 @default.
• W2012271610 crossrefType "journal-article" @default.
• W2012271610 hasAuthorship W2012271610A5000451929 @default.
• W2012271610 hasAuthorship W2012271610A5005879554 @default.
• W2012271610 hasAuthorship W2012271610A5007360478 @default.
• W2012271610 hasAuthorship W2012271610A5007774900 @default.
• W2012271610 hasAuthorship W2012271610A5009234755 @default.
• W2012271610 hasAuthorship W2012271610A5029893660 @default.
• W2012271610 hasAuthorship W2012271610A5033560168 @default.
• W2012271610 hasAuthorship W2012271610A5041745058 @default.
• W2012271610 hasAuthorship W2012271610A5042096090 @default.
• W2012271610 hasAuthorship W2012271610A5045230785 @default.
• W2012271610 hasAuthorship W2012271610A5046296775 @default.
• W2012271610 hasAuthorship W2012271610A5047405500 @default.
• W2012271610 hasAuthorship W2012271610A5049719522 @default.
• W2012271610 hasAuthorship W2012271610A5081294489 @default.
• W2012271610 hasBestOaLocation W20122716102 @default.
• W2012271610 hasConcept C104317684 @default.
• W2012271610 hasConcept C114851261 @default.
• W2012271610 hasConcept C126322002 @default.
• W2012271610 hasConcept C135763542 @default.
• W2012271610 hasConcept C142462285 @default.
• W2012271610 hasConcept C156719811 @default.
• W2012271610 hasConcept C159047783 @default.
• W2012271610 hasConcept C182707283 @default.
• W2012271610 hasConcept C2777351918 @default.
• W2012271610 hasConcept C2778451633 @default.
• W2012271610 hasConcept C2779182219 @default.
• W2012271610 hasConcept C2780345285 @default.
• W2012271610 hasConcept C2781413609 @default.
• W2012271610 hasConcept C2993143319 @default.
• W2012271610 hasConcept C3013748606 @default.
• W2012271610 hasConcept C31467283 @default.

• next